Hoshi Iryo-Sanki Co., Ltd.
Stock Price Chart
2026/11/06 19:48 UpdatedPrice Trend
2026/11/06 19:48 UpdatedPrice & Trading Details
2026/11/06 19:48 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/11/01Top Mutual Funds / ETFs
Updated 2026/11/01Major Holders
Updated 2026/11/01| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
Brighthouse Fd.s TRT II-Brighthouse/Dimensional Intl Small Company POR
|
300 | 0.00% |
Dividend History 4Years Growth
Updated 2026/11/08| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥90 | +12.5% |
| 2025 | ¥80 | +14.3% |
| 2024 | ¥70 | +7.7% |
| 2023 | ¥65 | +8.3% |
| 2022 | ¥60 | - |
Financial Performance
2026/11/08 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥13,780M | ¥14,778M | ¥15,102M | ¥15,520M |
| Gross Profit | ¥6,713M | ¥7,210M | ¥7,563M | ¥7,677M |
| Operating Income | ¥1,778M | ¥1,962M | ¥1,982M | ¥1,919M |
| Pretax Income | ¥1,798M | ¥2,051M | ¥2,069M | ¥2,010M |
| Net Income | ¥1,254M | ¥1,404M | ¥1,463M | ¥1,373M |
| EPS | ¥402.98 | ¥450.70 | ¥469.18 | ¥439.59 |
| Operating Margin | 12.90% | 13.27% | 13.13% | 12.37% |
| Balance Sheet | ||||
| Total Assets | ¥21,247M | ¥23,037M | ¥24,590M | ¥26,744M |
| Total Equity | ¥15,366M | ¥17,098M | ¥18,430M | ¥20,005M |
| Total Liabilities | ¥5,881M | ¥5,939M | ¥6,160M | ¥6,738M |
| Cash | ¥9,031M | ¥9,756M | ¥10,626M | ¥11,211M |
| Interest-bearing Debt | ¥1,001M | ¥834M | ¥1,093M | ¥1,283M |
| Equity Ratio | 72.32% | 74.22% | 74.95% | 74.80% |
| D/E Ratio | 0.07 | 0.05 | 0.06 | 0.06 |
| Cash Flow | ||||
| Operating CF | ¥2,288M | ¥2,395M | ¥2,190M | ¥2,477M |
| Investing CF | -¥1,059M | -¥745M | -¥5,285M | -¥1,544M |
| Financing CF | -¥958M | -¥903M | -¥740M | -¥948M |
| Free CF | ¥1,719M | ¥2,143M | ¥1,640M | ¥2,093M |
| Efficiency | ||||
| ROE | 8.16% | 8.21% | 7.94% | 6.86% |
| ROA | 5.90% | 6.10% | 5.95% | 5.13% |
Latest IR Information
-
Hoshi Iryo-Sanki Co., Ltd. Financial Summary for the Six Months Ended March 2027 (Q2)
For the six months ended March 2027, consolidated net sales were 7,839 million yen (Year-over-Year (YoY) increase of 6.3%), operating income was 958 million yen (YoY increase of 11.0%), ordinary income was 1,013 million yen, and net income attributable to...
Read more -
Notice Regarding Dividend of Surplus (Interim Dividend) and Revision of Year-end Dividend Forecast (Increase)
Revised interim and year-end dividend forecasts, raising the annual dividend forecast to 100 yen. Interim dividend is 50 yen per share, year-end dividend is 50 yen, effective date December 1, 2026. This is an increase from the previous forecast, funded...
Read more
Latest News (5 items)
Company Information
About
Hoshi Iryo-Sanki Co., Ltd. manufactures and sells pharmaceutical medical oxygen and nitrous oxides in Japan. The company operates through the five segments: Medical Gas Related Business; Home Medical Care Related Business; Medical Gas Equipment Construction Related Business; Nursing Care and Welfare Related Business; and Nursing Care Facility-Related Business. The Medical Gas Related Business segment sells medical oxygen gas, anesthetic gas, and other general medical gases. The Home Medical Care Related Business segment rents and sells oxygen concentrators for home oxygen therapy, continuous positive airway pressure therapy equipment, and home ventilators. The Medical Gas Equipment Construction Related Business segment designs and constructs medical gas piping works, as well as maintains and inspects medical gas piping equipment. The Nursing Care and Welfare Related Business segment offers rental and sale of care and welfare-related goods and equipment, home renovation, visiting nursing, and home care support services. The Nursing Care Facility-Related Business segment operates the paid nursing homes and day care facilities, and other related operations. Hoshi Iryo-Sanki Co., Ltd. was founded in 1960 and is headquartered in Adachi, Japan.
